ANGLE plc (LON:AGL – Get Free Report) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 3.48 and traded as low as GBX 2.33. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares changing hands.
ANGLE Price Performance
The company has a debt-to-equity ratio of 17.22, a current ratio of 5.19 and a quick ratio of 6.18. The company’s 50-day simple moving average is GBX 2.35 and its 200 day simple moving average is GBX 3.48. The firm has a market cap of £7.58 million, a P/E ratio of -0.49 and a beta of 0.22.
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Further Reading
- Five stocks we like better than ANGLE
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
